Immunwork
Taiwan - TaipeiBiotechnology
Focus: Immunwork is a Taiwan-based biotechnology company specializing in antibody platform technology, founded in 2014 and currently operating as a public entity. The company focuses on leveraging its proprietary antibody discovery and development capabilities in the competitive biotech landscape.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Immunwork
AI assessmentNot HiringNo open roles listed right now. Follow Immunwork to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TE-8214 - SAD
AcromegalyClinical Trials (1)
NCT06372652A Phase 1 Study of TE-8214 Solution in Healthy Volunteers
Phase 1Help build intelligence for Immunwork
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.